In a study conducted in US administrative claims data, TNF inhibitors and hydroxychloroquine were associated with a reduced risk of diabetes when compared to other non-biologic DMARDs (nbDMARDs) [15]. This evidence concerns the gene TNF and diabetes mellitus.